Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$7.96 - $13.59 $118,206 - $201,811
-14,850 Reduced 16.57%
74,761 $629,000
Q1 2024

May 13, 2024

SELL
$13.56 - $20.78 $146,217 - $224,070
-10,783 Reduced 10.74%
89,611 $1.29 Million
Q4 2023

Feb 13, 2024

BUY
$14.18 - $22.31 $532,955 - $838,521
37,585 Added 59.84%
100,394 $2.16 Million
Q3 2023

Nov 13, 2023

BUY
$18.22 - $25.85 $190,963 - $270,933
10,481 Added 20.03%
62,809 $1.21 Million
Q2 2023

Aug 04, 2023

SELL
$22.62 - $39.32 $48,225 - $83,830
-2,132 Reduced 3.91%
52,328 $1.33 Million
Q1 2023

May 11, 2023

BUY
$30.17 - $41.11 $57,745 - $78,684
1,914 Added 3.64%
54,460 $1.97 Million
Q4 2022

Feb 07, 2023

BUY
$36.43 - $49.4 $409,618 - $555,453
11,244 Added 27.22%
52,546 $2.08 Million
Q3 2022

Nov 10, 2022

SELL
$40.66 - $53.03 $437,460 - $570,549
-10,759 Reduced 20.67%
41,302 $1.93 Million
Q2 2022

Aug 03, 2022

BUY
$40.85 - $77.67 $519,326 - $987,418
12,713 Added 32.31%
52,061 $2.28 Million
Q1 2022

May 04, 2022

SELL
$59.95 - $92.06 $212,342 - $326,076
-3,542 Reduced 8.26%
39,348 $2.85 Million
Q4 2021

Feb 04, 2022

SELL
$81.07 - $121.29 $451,559 - $675,585
-5,570 Reduced 11.49%
42,890 $3.48 Million
Q3 2021

Oct 07, 2021

SELL
$101.99 - $166.36 $476,089 - $776,568
-4,668 Reduced 8.79%
48,460 $5.64 Million
Q2 2021

Aug 04, 2021

BUY
$141.6 - $179.06 $1.01 Million - $1.28 Million
7,150 Added 15.55%
53,128 $8.81 Million
Q1 2021

May 04, 2021

BUY
$132.81 - $182.18 $4.32 Million - $5.92 Million
32,497 Added 241.06%
45,978 $6.41 Million
Q4 2020

Feb 02, 2021

BUY
$138.17 - $184.34 $83,316 - $111,157
603 Added 4.68%
13,481 $2.33 Million
Q3 2020

Oct 09, 2020

BUY
$114.09 - $145.51 $82,943 - $105,785
727 Added 5.98%
12,878 $1.79 Million
Q2 2020

Jul 08, 2020

SELL
$89.45 - $129.85 $11,449 - $16,620
-128 Reduced 1.04%
12,151 $1.45 Million
Q1 2020

Apr 23, 2020

SELL
$70.23 - $144.31 $26,687 - $54,837
-380 Reduced 3.0%
12,279 $1.23 Million
Q4 2019

Feb 11, 2020

SELL
$76.41 - $117.54 $263,156 - $404,807
-3,444 Reduced 21.39%
12,659 $1.49 Million
Q3 2019

Oct 17, 2019

BUY
$61.52 - $91.1 $178,408 - $264,190
2,900 Added 21.96%
16,103 $1.38 Million
Q2 2019

Aug 02, 2019

BUY
$58.04 - $66.99 $118,575 - $136,860
2,043 Added 18.31%
13,203 $856,000
Q1 2019

May 10, 2019

BUY
$35.52 - $62.62 $125,065 - $220,485
3,521 Added 46.09%
11,160 $698,000
Q4 2018

Feb 13, 2019

BUY
$35.43 - $56.29 $270,649 - $429,999
7,639 New
7,639 $297,000
Q3 2018

Nov 14, 2018

SELL
$44.22 - $75.47 $147,783 - $252,220
-3,342 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$72.38 - $92.5 $8,178 - $10,452
-113 Reduced 3.27%
3,342 $267,000
Q1 2018

May 09, 2018

BUY
$69.46 - $88.57 $20,004 - $25,508
288 Added 9.09%
3,455 $299,000
Q4 2017

Feb 20, 2018

BUY
$65.94 - $93.31 $11,671 - $16,515
177 Added 5.92%
3,167 $218,000
Q3 2017

Nov 13, 2017

SELL
$80.87 - $91.08 $33,884 - $38,162
-419 Reduced 12.29%
2,990 $270,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,409
3,409 $253,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $140M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.